miRNA介绍、命名原则、功能分析、miRNA数据库大全

2016-01-08 MedSci MedSci原创

microRNA(miRNA)是一类长度约为19-25nt的内源性非编码RNA,广泛参与基因转录后调控活动,其中多数miRNA具有高度序列保守性、表达时序性和组织特异性。最近的研究表明miRNA参与各种各样的调节途径,包括发育、病毒防御、造血过程、器官形成、细胞增殖和凋亡、脂肪代谢等,具有重要的基因表达调控作用。 pri-miRNA, pre-miRNA 和 mature miRNA有什么区

microRNA(miRNA)是一类长度约为19-25nt的内源性非编码RNA,广泛参与基因转录后调控活动,其中多数miRNA具有高度序列保守性、表达时序性和组织特异性。最近的研究表明miRNA参与各种各样的调节途径,包括发育、病毒防御、造血过程、器官形成、细胞增殖和凋亡、脂肪代谢等,具有重要的基因表达调控作用。

pri-miRNA, pre-miRNA 和 mature miRNA有什么区别

成熟的miRNAs是由较长的初级转录物经过一系列核酸酶的剪切加工而产生的,初级转录物称为pri-miRNA。pri-miRNA长度从几百到几千个碱基不等,带有5‘帽子和3’polyA尾巴,以及1到数个发夹径环结构。Pri-miRNA经剪切产生约70个碱基的miRNA前体,即pre-miRNA。pre-miRNA为单一发夹结构,5‘带有磷酸基团,3’有两个突出碱基,并带有3‘羟基。pre-miRNA经进一步剪切,形成长度约为22个碱基的单链成熟miRNA。

MiRNA的命名原则可以大致归纳如下

一个系统命名包含三部分内容,即物种,microRNA类别,序号。三者间用短线连接。物种一般用三个小写字母表示,如hsa,mmu和rno分别代表人,小鼠和大鼠。MicroRNA类别是指所命名的microRNA是pre-miRNA还是mature miRNA。pre-miRNA用mir表示,mature miRNA用miR表示。序号为一阿拉伯数字,代表microRNA发现的先后。一般而言,数字越小,发现越早。

位于基因组不同部位但产生同样的mature miRNA的pre-miRNA在序号后添加短线和阿拉伯数字以示区别,如hsa-mir-7-1, hsa-mir-7-2, hsa-mir-7-3。

有些pre-miRNA可以产生两个mature miRNA。对应pre-miRNA茎环结构5‘和3‘序列的mature miRNA分别加后缀-5p和-3p以示区分,如rno-miR-325-5p和rno-miR-325-3p。

如果从同一个pre-miRNA成熟的两个mature miRNA的相对表达量已知,表达量高者加后缀*,如hsa-miR-17*比hsa-miR-17表达量高。

对于仅相差1-2个碱基的mature miRNA,加一个小写字母后缀以示区别,如hsa-miR-19a, hsa-miR-19b。 
如何分析miRNA的功能?
一般利用一些常见的miRNA数据库进行分析,MedSci编辑只能告诉你这么多了,因为它足够多了,主要包括: miRBasemicrornaTargetScanPicTarmiRandaHOCTARMiRTarBasemiRDBmirna databasemiRNAMapmiRCancer(肿瘤miRNA),miR2DiseasemicroRNA target predictionMicro RNA InformaticsPMTED(植物miRNA),miRWalk2.0,ViTa(病毒领域miRNA),PITA,starBase v2.0,以及COMETA {nextpage}
miRNA数据库,以及靶点预测介绍:
(1)miRbase:众所周知的microRNA基因注释数据库。目前miRBase只提供了microRNA的靶标的预测软件的链接(如:PicTar)。最新版本发布时间:2010年9月。网址:http://mirbase.org/index.shtml

(2)ChIPBase: 整合CLIP-Seq和ChIP-Seq的数据探讨microRNA的转录和转录后调控,构建转录因子->microRNA->靶标的调控网络。最新版本发布时间:2012年11月。网址:http://deepbase.sysu.edu.cn/chipbase/

(3)starBase:一个高通量实验数据CLIP-Seq(或称为HITS-CLIP)和mRNA降解组测序数据支持的microRNA靶标数据库,整合和构建多个流行的靶标预测软件的交集和调控关系。
最新版本发布时间:2011年5月。 网址:http://starbase.sysu.edu.cn/

(4)Tarbase:一个收集已被实验验证的microRNA靶标数据库。最新版本发布时间:2009年1月(v5)。网址:http://microrna.gr/tarbase/ 

(5)miRecords:一个整合的microRNA靶标数据库。整合多个靶标预测软件的调控关系。最新版本发布时间:2010年11月。网址:http://mirecords.biolead.org/

(6)targetScan: 基于靶mRNA序列的进化保守等特征搜寻动物的microRNA靶基因。是预测microRNA靶标假阳性率较低的软件。而且是microRNA领域大牛Bartel实验室开发的。最新版本发布时间:2009年4月(v5.1). 网址:http://www.targetscan.org/

(7)PicTar:基于microRNA或microRNA靶标联合作用等特征开发的搜寻动物的microRNA靶基因。假阳性率也较低。是microRNA领域大牛Rajewsky实验室开发的。最新版本发布时间:2007年3月。网址:http://pictar.mdc-berlin.de/

(8)PITA:基于靶位点的可接性(target-site accessibility)和自由能预测microRNA的靶标。是著名的生物信息学家Segal实验室开发的。最新版本发布时间:2008年8月。网址:http://genie.weizmann.ac.il/pubs/mir07/mir07_data.html

(9)RNA22:基于序列特征预测microRNA的结合位点。是几个流行的microRNA靶标预测软件的其中一个。IBM公司的研究团队开发的。最新版本发布时间:2007年。网址:http://cbcsrv.watson.ibm.com/rna22.html

(10)miRanda和microRNA.org:是著名的Memorial Sloan-Kettering 癌症研究中心的研究人员开发的软件和数据库。miRanda的最新版本又叫mirSVR。最新版本发布时间:2010年8月。网址:http://www.microrna.org/microrna/home.do

(11)MicroCosm:EMBL-EBI的Enright 实验室开发的microRNA靶标数据库。最新版本发布时间:2010年8月。网址:http://www.ebi.ac.uk/enright-srv/microcosm/htdocs/targets/v5/

(12)miRTarBase:整合实验证实的microRNA靶标的数据库。最新版本发布时间:2010年10月。网址:http://mirtarbase.mbc.nctu.edu.tw/index.html

(13)miRGator v2.0:整合microRNA表达、靶标和疾病相关信息的数据库。最新版本发布时间:2010年11月。网址:http://mirgator.kobic.re.kr:8080/MEXWebApp/

(14)MiRNAMap:动物的microRNA基因及其靶标的数据库。最新版本发布时间:2008年1月。网址:http://mirnamap.mbc.nctu.edu.tw/

(15)miRDB: 动物microRNA靶标预测和功能注释数据库。最新版本发布时间:2010年8月。网址:http://mirdb.org/miRDB/

(16)RNAhybrid:一个基于miRNA-target配对自由能预测microRNA的靶标。最新版本发布时间:v2.1。网址:http://bibiserv.techfak.uni-bielefeld.de/rnahybrid/

(17)miRGen:microRNA基因和microRNA靶标数据库。最新版本发布时间:2007年1月。网址:http://www.diana.pcbi.upenn.edu/miRGen.html

(18)doRiNA: microRNA的转录后调控数据库。最新版本发布时间:2012年1月。网址:http://dorina.mdc-berlin.de/rbp_browser/dorina.html 
(19)COMETA:通过miRNA靶基因共表达相关性分析数据库(CoMeTa),优化和筛减miRNA靶基因集合  
{nextpage}
预测植物microRNA靶标的工具和数据库如下:

(1) Targetfinder: 使用基于植物的靶标罚分策略预测小RNA的靶标。最新版本发布时间:2010年8月。网址:http://jcclab.science.oregonstate.edu/node/view/56334

(2) starBase: 提供高通量实验数据mRNA降解组测序数据支持的植物microRNA靶标数据库和基于mRNA降解组数据预测microRNA靶标的网页版工具。最新版本发布时间:2011年5月。 网址:http://starbase.sysu.edu.cn/

(3) miRU, psRNATarget: 一个网页版的植物microRNA靶标预测工具。最新版本发布时间:2011年5月。 网址:http://www.plantgrn.org/psRNATarget/

(4)CleaveLand:一个基于mRNA降解组数据预测microRNA靶标的工具。最新版本发布时间:2010年3月。网址:https://homes.bio.psu.edu/people/faculty/Axtell/AxtellLab/Software.html

(5) Target-align:一个就鉴定植物microRNA靶标的工具。最新版本发布时间:2010年。网址:http://www.leonxie.com/targetAlign.php
{nextpage}
miRNA-lncRNA互作的数据库:
starBase: 提供miRNA调控长非编码RNA(lncRNA)、假基因(pseudogene)和环状RNA(circRNA)的互作信息。并且根据这些互作关系还 构建了ceRNA调控网络。这些调控互作网络信息是基于108高通量的CLIP-Seq实验数据。网 站:http://starbase.sysu.edu.cn 更新: 2013年

DIANA-LncBase: 提供基于2个研究的CLIP-Seq数据miRNA调控长非编码RNA(lncRNA)的信息。网站:www.microrna.gr/LncBase 更新: 2012年 

各个数据库特点:
其中数据库中全面和更新快的有:
miRBase: http://mirbase.org/index.shtml
starBase: http://starbase.sysu.edu.cn/
miRecords: http://mirecords.biolead.org/
miRTarBase: http://mirtarbase.mbc.nctu.edu.tw/index.html

预测软件假阳性率低的有:
targetScan:http://www.targetscan.org/ 
PicTar: http://pictar.mdc-berlin.de/
当然,大家若不是做miRNA,要做LncRNA,怎么办?可以看这里:长链非编码RNA(lncRNA)靶标数据库及预测软件汇总 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (16)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=881415, encodeId=dddd8814153f, content=带星号的是表达量比较少的吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a3f2301740, createdName=神经病, createdTime=Mon Aug 31 15:48:18 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=192676, encodeId=6a281926e6e3, content=很不错,很实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4WNjP27icCGpcMIYzwXoBb45O0gUbhu7icxyn5aUozYvDpFZ0RmaRCQ484wv4lkv6pkvruWNPgnMCQ/0, createdBy=e0df2055248, createdName=徐乐乐, createdTime=Tue May 02 04:03:13 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930423, encodeId=0f891930423be, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Sun Nov 20 19:26:00 CST 2016, time=2016-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90557, encodeId=dc669055ef9, content=先收藏着, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b711667381, createdName=JBY, createdTime=Sun Jun 19 22:11:00 CST 2016, time=2016-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90558, encodeId=3e8d9055884, content=好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b711667381, createdName=JBY, createdTime=Sun Jun 19 22:11:00 CST 2016, time=2016-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809960, encodeId=9aae1809960c6, content=<a href='/topic/show?id=2b9d8426121' target=_blank style='color:#2F92EE;'>#能分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84261, encryptionId=2b9d8426121, topicName=能分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sun Jan 31 12:26:00 CST 2016, time=2016-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85107, encodeId=3ec98510ee8, content=数据库大全,但是不切题啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73c1706459, createdName=1de92651m76(暂无匿称), createdTime=Mon May 09 18:44:00 CST 2016, time=2016-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56793, encodeId=a3cb56e9326, content=看不懂, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160113/IMG569619FEB03536446.jpg, createdBy=85f81678980, createdName=Lynee劲飞扬, createdTime=Wed Jan 13 11:41:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312272, encodeId=337013122e20c, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Sun Jan 10 01:26:00 CST 2016, time=2016-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54599, encodeId=d586545993d, content=好高端的样子, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151027/IMG562EB376ED6788263.jpg, createdBy=e6ea1659259, createdName=木醇阳, createdTime=Fri Jan 08 11:55:00 CST 2016, time=2016-01-08, status=1, ipAttribution=)]
    2020-08-31 神经病

    带星号的是表达量比较少的吧

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=881415, encodeId=dddd8814153f, content=带星号的是表达量比较少的吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a3f2301740, createdName=神经病, createdTime=Mon Aug 31 15:48:18 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=192676, encodeId=6a281926e6e3, content=很不错,很实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4WNjP27icCGpcMIYzwXoBb45O0gUbhu7icxyn5aUozYvDpFZ0RmaRCQ484wv4lkv6pkvruWNPgnMCQ/0, createdBy=e0df2055248, createdName=徐乐乐, createdTime=Tue May 02 04:03:13 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930423, encodeId=0f891930423be, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Sun Nov 20 19:26:00 CST 2016, time=2016-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90557, encodeId=dc669055ef9, content=先收藏着, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b711667381, createdName=JBY, createdTime=Sun Jun 19 22:11:00 CST 2016, time=2016-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90558, encodeId=3e8d9055884, content=好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b711667381, createdName=JBY, createdTime=Sun Jun 19 22:11:00 CST 2016, time=2016-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809960, encodeId=9aae1809960c6, content=<a href='/topic/show?id=2b9d8426121' target=_blank style='color:#2F92EE;'>#能分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84261, encryptionId=2b9d8426121, topicName=能分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sun Jan 31 12:26:00 CST 2016, time=2016-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85107, encodeId=3ec98510ee8, content=数据库大全,但是不切题啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73c1706459, createdName=1de92651m76(暂无匿称), createdTime=Mon May 09 18:44:00 CST 2016, time=2016-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56793, encodeId=a3cb56e9326, content=看不懂, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160113/IMG569619FEB03536446.jpg, createdBy=85f81678980, createdName=Lynee劲飞扬, createdTime=Wed Jan 13 11:41:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312272, encodeId=337013122e20c, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Sun Jan 10 01:26:00 CST 2016, time=2016-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54599, encodeId=d586545993d, content=好高端的样子, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151027/IMG562EB376ED6788263.jpg, createdBy=e6ea1659259, createdName=木醇阳, createdTime=Fri Jan 08 11:55:00 CST 2016, time=2016-01-08, status=1, ipAttribution=)]
    2017-05-02 徐乐乐

    很不错,很实用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=881415, encodeId=dddd8814153f, content=带星号的是表达量比较少的吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a3f2301740, createdName=神经病, createdTime=Mon Aug 31 15:48:18 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=192676, encodeId=6a281926e6e3, content=很不错,很实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4WNjP27icCGpcMIYzwXoBb45O0gUbhu7icxyn5aUozYvDpFZ0RmaRCQ484wv4lkv6pkvruWNPgnMCQ/0, createdBy=e0df2055248, createdName=徐乐乐, createdTime=Tue May 02 04:03:13 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930423, encodeId=0f891930423be, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Sun Nov 20 19:26:00 CST 2016, time=2016-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90557, encodeId=dc669055ef9, content=先收藏着, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b711667381, createdName=JBY, createdTime=Sun Jun 19 22:11:00 CST 2016, time=2016-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90558, encodeId=3e8d9055884, content=好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b711667381, createdName=JBY, createdTime=Sun Jun 19 22:11:00 CST 2016, time=2016-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809960, encodeId=9aae1809960c6, content=<a href='/topic/show?id=2b9d8426121' target=_blank style='color:#2F92EE;'>#能分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84261, encryptionId=2b9d8426121, topicName=能分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sun Jan 31 12:26:00 CST 2016, time=2016-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85107, encodeId=3ec98510ee8, content=数据库大全,但是不切题啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73c1706459, createdName=1de92651m76(暂无匿称), createdTime=Mon May 09 18:44:00 CST 2016, time=2016-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56793, encodeId=a3cb56e9326, content=看不懂, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160113/IMG569619FEB03536446.jpg, createdBy=85f81678980, createdName=Lynee劲飞扬, createdTime=Wed Jan 13 11:41:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312272, encodeId=337013122e20c, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Sun Jan 10 01:26:00 CST 2016, time=2016-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54599, encodeId=d586545993d, content=好高端的样子, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151027/IMG562EB376ED6788263.jpg, createdBy=e6ea1659259, createdName=木醇阳, createdTime=Fri Jan 08 11:55:00 CST 2016, time=2016-01-08, status=1, ipAttribution=)]
    2016-11-20 smallant2002
  4. [GetPortalCommentsPageByObjectIdResponse(id=881415, encodeId=dddd8814153f, content=带星号的是表达量比较少的吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a3f2301740, createdName=神经病, createdTime=Mon Aug 31 15:48:18 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=192676, encodeId=6a281926e6e3, content=很不错,很实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4WNjP27icCGpcMIYzwXoBb45O0gUbhu7icxyn5aUozYvDpFZ0RmaRCQ484wv4lkv6pkvruWNPgnMCQ/0, createdBy=e0df2055248, createdName=徐乐乐, createdTime=Tue May 02 04:03:13 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930423, encodeId=0f891930423be, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Sun Nov 20 19:26:00 CST 2016, time=2016-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90557, encodeId=dc669055ef9, content=先收藏着, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b711667381, createdName=JBY, createdTime=Sun Jun 19 22:11:00 CST 2016, time=2016-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90558, encodeId=3e8d9055884, content=好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b711667381, createdName=JBY, createdTime=Sun Jun 19 22:11:00 CST 2016, time=2016-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809960, encodeId=9aae1809960c6, content=<a href='/topic/show?id=2b9d8426121' target=_blank style='color:#2F92EE;'>#能分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84261, encryptionId=2b9d8426121, topicName=能分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sun Jan 31 12:26:00 CST 2016, time=2016-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85107, encodeId=3ec98510ee8, content=数据库大全,但是不切题啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73c1706459, createdName=1de92651m76(暂无匿称), createdTime=Mon May 09 18:44:00 CST 2016, time=2016-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56793, encodeId=a3cb56e9326, content=看不懂, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160113/IMG569619FEB03536446.jpg, createdBy=85f81678980, createdName=Lynee劲飞扬, createdTime=Wed Jan 13 11:41:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312272, encodeId=337013122e20c, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Sun Jan 10 01:26:00 CST 2016, time=2016-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54599, encodeId=d586545993d, content=好高端的样子, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151027/IMG562EB376ED6788263.jpg, createdBy=e6ea1659259, createdName=木醇阳, createdTime=Fri Jan 08 11:55:00 CST 2016, time=2016-01-08, status=1, ipAttribution=)]
    2016-06-19 JBY

    先收藏着

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=881415, encodeId=dddd8814153f, content=带星号的是表达量比较少的吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a3f2301740, createdName=神经病, createdTime=Mon Aug 31 15:48:18 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=192676, encodeId=6a281926e6e3, content=很不错,很实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4WNjP27icCGpcMIYzwXoBb45O0gUbhu7icxyn5aUozYvDpFZ0RmaRCQ484wv4lkv6pkvruWNPgnMCQ/0, createdBy=e0df2055248, createdName=徐乐乐, createdTime=Tue May 02 04:03:13 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930423, encodeId=0f891930423be, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Sun Nov 20 19:26:00 CST 2016, time=2016-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90557, encodeId=dc669055ef9, content=先收藏着, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b711667381, createdName=JBY, createdTime=Sun Jun 19 22:11:00 CST 2016, time=2016-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90558, encodeId=3e8d9055884, content=好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b711667381, createdName=JBY, createdTime=Sun Jun 19 22:11:00 CST 2016, time=2016-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809960, encodeId=9aae1809960c6, content=<a href='/topic/show?id=2b9d8426121' target=_blank style='color:#2F92EE;'>#能分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84261, encryptionId=2b9d8426121, topicName=能分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sun Jan 31 12:26:00 CST 2016, time=2016-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85107, encodeId=3ec98510ee8, content=数据库大全,但是不切题啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73c1706459, createdName=1de92651m76(暂无匿称), createdTime=Mon May 09 18:44:00 CST 2016, time=2016-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56793, encodeId=a3cb56e9326, content=看不懂, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160113/IMG569619FEB03536446.jpg, createdBy=85f81678980, createdName=Lynee劲飞扬, createdTime=Wed Jan 13 11:41:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312272, encodeId=337013122e20c, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Sun Jan 10 01:26:00 CST 2016, time=2016-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54599, encodeId=d586545993d, content=好高端的样子, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151027/IMG562EB376ED6788263.jpg, createdBy=e6ea1659259, createdName=木醇阳, createdTime=Fri Jan 08 11:55:00 CST 2016, time=2016-01-08, status=1, ipAttribution=)]
    2016-06-19 JBY

    好好好好

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=881415, encodeId=dddd8814153f, content=带星号的是表达量比较少的吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a3f2301740, createdName=神经病, createdTime=Mon Aug 31 15:48:18 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=192676, encodeId=6a281926e6e3, content=很不错,很实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4WNjP27icCGpcMIYzwXoBb45O0gUbhu7icxyn5aUozYvDpFZ0RmaRCQ484wv4lkv6pkvruWNPgnMCQ/0, createdBy=e0df2055248, createdName=徐乐乐, createdTime=Tue May 02 04:03:13 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930423, encodeId=0f891930423be, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Sun Nov 20 19:26:00 CST 2016, time=2016-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90557, encodeId=dc669055ef9, content=先收藏着, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b711667381, createdName=JBY, createdTime=Sun Jun 19 22:11:00 CST 2016, time=2016-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90558, encodeId=3e8d9055884, content=好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b711667381, createdName=JBY, createdTime=Sun Jun 19 22:11:00 CST 2016, time=2016-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809960, encodeId=9aae1809960c6, content=<a href='/topic/show?id=2b9d8426121' target=_blank style='color:#2F92EE;'>#能分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84261, encryptionId=2b9d8426121, topicName=能分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sun Jan 31 12:26:00 CST 2016, time=2016-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85107, encodeId=3ec98510ee8, content=数据库大全,但是不切题啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73c1706459, createdName=1de92651m76(暂无匿称), createdTime=Mon May 09 18:44:00 CST 2016, time=2016-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56793, encodeId=a3cb56e9326, content=看不懂, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160113/IMG569619FEB03536446.jpg, createdBy=85f81678980, createdName=Lynee劲飞扬, createdTime=Wed Jan 13 11:41:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312272, encodeId=337013122e20c, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Sun Jan 10 01:26:00 CST 2016, time=2016-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54599, encodeId=d586545993d, content=好高端的样子, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151027/IMG562EB376ED6788263.jpg, createdBy=e6ea1659259, createdName=木醇阳, createdTime=Fri Jan 08 11:55:00 CST 2016, time=2016-01-08, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=881415, encodeId=dddd8814153f, content=带星号的是表达量比较少的吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a3f2301740, createdName=神经病, createdTime=Mon Aug 31 15:48:18 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=192676, encodeId=6a281926e6e3, content=很不错,很实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4WNjP27icCGpcMIYzwXoBb45O0gUbhu7icxyn5aUozYvDpFZ0RmaRCQ484wv4lkv6pkvruWNPgnMCQ/0, createdBy=e0df2055248, createdName=徐乐乐, createdTime=Tue May 02 04:03:13 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930423, encodeId=0f891930423be, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Sun Nov 20 19:26:00 CST 2016, time=2016-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90557, encodeId=dc669055ef9, content=先收藏着, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b711667381, createdName=JBY, createdTime=Sun Jun 19 22:11:00 CST 2016, time=2016-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90558, encodeId=3e8d9055884, content=好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b711667381, createdName=JBY, createdTime=Sun Jun 19 22:11:00 CST 2016, time=2016-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809960, encodeId=9aae1809960c6, content=<a href='/topic/show?id=2b9d8426121' target=_blank style='color:#2F92EE;'>#能分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84261, encryptionId=2b9d8426121, topicName=能分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sun Jan 31 12:26:00 CST 2016, time=2016-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85107, encodeId=3ec98510ee8, content=数据库大全,但是不切题啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73c1706459, createdName=1de92651m76(暂无匿称), createdTime=Mon May 09 18:44:00 CST 2016, time=2016-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56793, encodeId=a3cb56e9326, content=看不懂, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160113/IMG569619FEB03536446.jpg, createdBy=85f81678980, createdName=Lynee劲飞扬, createdTime=Wed Jan 13 11:41:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312272, encodeId=337013122e20c, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Sun Jan 10 01:26:00 CST 2016, time=2016-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54599, encodeId=d586545993d, content=好高端的样子, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151027/IMG562EB376ED6788263.jpg, createdBy=e6ea1659259, createdName=木醇阳, createdTime=Fri Jan 08 11:55:00 CST 2016, time=2016-01-08, status=1, ipAttribution=)]
    2016-05-09 1de92651m76(暂无匿称)

    数据库大全,但是不切题啊!

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=881415, encodeId=dddd8814153f, content=带星号的是表达量比较少的吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a3f2301740, createdName=神经病, createdTime=Mon Aug 31 15:48:18 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=192676, encodeId=6a281926e6e3, content=很不错,很实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4WNjP27icCGpcMIYzwXoBb45O0gUbhu7icxyn5aUozYvDpFZ0RmaRCQ484wv4lkv6pkvruWNPgnMCQ/0, createdBy=e0df2055248, createdName=徐乐乐, createdTime=Tue May 02 04:03:13 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930423, encodeId=0f891930423be, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Sun Nov 20 19:26:00 CST 2016, time=2016-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90557, encodeId=dc669055ef9, content=先收藏着, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b711667381, createdName=JBY, createdTime=Sun Jun 19 22:11:00 CST 2016, time=2016-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90558, encodeId=3e8d9055884, content=好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b711667381, createdName=JBY, createdTime=Sun Jun 19 22:11:00 CST 2016, time=2016-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809960, encodeId=9aae1809960c6, content=<a href='/topic/show?id=2b9d8426121' target=_blank style='color:#2F92EE;'>#能分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84261, encryptionId=2b9d8426121, topicName=能分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sun Jan 31 12:26:00 CST 2016, time=2016-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85107, encodeId=3ec98510ee8, content=数据库大全,但是不切题啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73c1706459, createdName=1de92651m76(暂无匿称), createdTime=Mon May 09 18:44:00 CST 2016, time=2016-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56793, encodeId=a3cb56e9326, content=看不懂, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160113/IMG569619FEB03536446.jpg, createdBy=85f81678980, createdName=Lynee劲飞扬, createdTime=Wed Jan 13 11:41:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312272, encodeId=337013122e20c, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Sun Jan 10 01:26:00 CST 2016, time=2016-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54599, encodeId=d586545993d, content=好高端的样子, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151027/IMG562EB376ED6788263.jpg, createdBy=e6ea1659259, createdName=木醇阳, createdTime=Fri Jan 08 11:55:00 CST 2016, time=2016-01-08, status=1, ipAttribution=)]
    2016-01-13 Lynee劲飞扬

    看不懂

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=881415, encodeId=dddd8814153f, content=带星号的是表达量比较少的吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a3f2301740, createdName=神经病, createdTime=Mon Aug 31 15:48:18 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=192676, encodeId=6a281926e6e3, content=很不错,很实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4WNjP27icCGpcMIYzwXoBb45O0gUbhu7icxyn5aUozYvDpFZ0RmaRCQ484wv4lkv6pkvruWNPgnMCQ/0, createdBy=e0df2055248, createdName=徐乐乐, createdTime=Tue May 02 04:03:13 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930423, encodeId=0f891930423be, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Sun Nov 20 19:26:00 CST 2016, time=2016-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90557, encodeId=dc669055ef9, content=先收藏着, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b711667381, createdName=JBY, createdTime=Sun Jun 19 22:11:00 CST 2016, time=2016-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90558, encodeId=3e8d9055884, content=好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b711667381, createdName=JBY, createdTime=Sun Jun 19 22:11:00 CST 2016, time=2016-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809960, encodeId=9aae1809960c6, content=<a href='/topic/show?id=2b9d8426121' target=_blank style='color:#2F92EE;'>#能分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84261, encryptionId=2b9d8426121, topicName=能分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sun Jan 31 12:26:00 CST 2016, time=2016-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85107, encodeId=3ec98510ee8, content=数据库大全,但是不切题啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73c1706459, createdName=1de92651m76(暂无匿称), createdTime=Mon May 09 18:44:00 CST 2016, time=2016-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56793, encodeId=a3cb56e9326, content=看不懂, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160113/IMG569619FEB03536446.jpg, createdBy=85f81678980, createdName=Lynee劲飞扬, createdTime=Wed Jan 13 11:41:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312272, encodeId=337013122e20c, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Sun Jan 10 01:26:00 CST 2016, time=2016-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54599, encodeId=d586545993d, content=好高端的样子, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151027/IMG562EB376ED6788263.jpg, createdBy=e6ea1659259, createdName=木醇阳, createdTime=Fri Jan 08 11:55:00 CST 2016, time=2016-01-08, status=1, ipAttribution=)]
    2016-01-10 Homburg
  10. [GetPortalCommentsPageByObjectIdResponse(id=881415, encodeId=dddd8814153f, content=带星号的是表达量比较少的吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a3f2301740, createdName=神经病, createdTime=Mon Aug 31 15:48:18 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=192676, encodeId=6a281926e6e3, content=很不错,很实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4WNjP27icCGpcMIYzwXoBb45O0gUbhu7icxyn5aUozYvDpFZ0RmaRCQ484wv4lkv6pkvruWNPgnMCQ/0, createdBy=e0df2055248, createdName=徐乐乐, createdTime=Tue May 02 04:03:13 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930423, encodeId=0f891930423be, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Sun Nov 20 19:26:00 CST 2016, time=2016-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90557, encodeId=dc669055ef9, content=先收藏着, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b711667381, createdName=JBY, createdTime=Sun Jun 19 22:11:00 CST 2016, time=2016-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90558, encodeId=3e8d9055884, content=好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b711667381, createdName=JBY, createdTime=Sun Jun 19 22:11:00 CST 2016, time=2016-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809960, encodeId=9aae1809960c6, content=<a href='/topic/show?id=2b9d8426121' target=_blank style='color:#2F92EE;'>#能分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84261, encryptionId=2b9d8426121, topicName=能分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sun Jan 31 12:26:00 CST 2016, time=2016-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85107, encodeId=3ec98510ee8, content=数据库大全,但是不切题啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73c1706459, createdName=1de92651m76(暂无匿称), createdTime=Mon May 09 18:44:00 CST 2016, time=2016-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56793, encodeId=a3cb56e9326, content=看不懂, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160113/IMG569619FEB03536446.jpg, createdBy=85f81678980, createdName=Lynee劲飞扬, createdTime=Wed Jan 13 11:41:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312272, encodeId=337013122e20c, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Sun Jan 10 01:26:00 CST 2016, time=2016-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=54599, encodeId=d586545993d, content=好高端的样子, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151027/IMG562EB376ED6788263.jpg, createdBy=e6ea1659259, createdName=木醇阳, createdTime=Fri Jan 08 11:55:00 CST 2016, time=2016-01-08, status=1, ipAttribution=)]
    2016-01-08 木醇阳

    好高端的样子

    0

相关资讯

miRNA 靶基因预测介绍

miRNA主要通过与靶mRNA的结合,或促使mRNA降解,或阻碍其翻译,从而抑制目的基因的表达。用生物信息学方法准确快速地预测miRNA的靶基因,可以为研究miRNA功能提供线索。 植物miRNA 靶基因的预测比较简单, 因为在植物中miRNA与靶基因几乎以完全互补配对的方式结合, 预测时无需复杂的算法。 计算方法的预测主要依赖于已经验证的miRNA和靶基因间的结合的规律。主要原则有:

Cancer Res:miR-100能减少乳腺肿瘤干细胞的生成 抑制肿瘤生长

中国科学技术大学生命学院教授柳素玲在肿瘤干细胞研究中取得新突破,发现一种叫作microRNA100(miR-100)的核糖核酸小分子可以抑制乳腺肿瘤干细胞的更新和增殖,从而扼制乳腺癌的生长和迁移。相关成果以长文形式在线发表于《癌症研究》杂志。   相关研究显示,乳腺肿瘤干细胞是乳腺癌对化疗和放疗产生抵抗的根源。microRNA是一类长度约22个核苷酸的非编码单链核糖核酸小分子,可以调节许多细

Biomarkers:四种miRNAs可能为早期诊断帕金森病的标志物

南京大学的张辰宇(Chen-Yu Zhang)主要从事microRNA、线粒体功能和人体及细胞能量代谢研究。近年来因发布了多项有关miRNA的惊人研究成果而广受关注。迄今已在包括Cell, Nature, Science及其子刊(~22篇)在内的国际学术期刊上发表论文约150余篇。

帕金森病又称"震颤麻痹",多在60岁前后发病。主要表现为患者动作缓慢,手脚或身体的其它部分的震颤,身体失去了柔软性,变得僵硬。由于帕金森病是一种慢性进行性中枢神经系统退行性疾病。早在临床前期尚未出现典型临床症状时,帕金森病患者即已出现神经系统退行性病变。因此,如果能在退行性病变早期及时明确诊断并予以治疗,将会减缓疾病进程,提高患者生活质量。但目前尚未获得早期诊断帕金森病的敏感、非侵入性生物标志物。

在这篇文章中,研究人员旨在探讨利用循环microRNAs (miRNAs)作为帕金森病新型生物标志物的可能性。他们利用Solexa测序技术和实时定量PCR · 2015-12-08

-->

Molecular cell:华人科学家发现mTOR抑制miRNA合成新机制

                                 

Nat Methods:12种miRNA表达平台的比较

microRNA(miRNA)作为基因表达的重要调节因子,在近年来被广泛研究。目前,人们利用各种不同的技术来确定生物样品中miRNA的相对丰度,包括小RNA测序、RT-qPCR和芯片等。这些技术究竟孰优孰劣?比利时根特大学领导的团队比较了12种miRNA表达分析平台,并将其结果发表在6月29日的《Nature Methods》在线版上。 miRNA虽小,却在许多生物过程中扮演了重要角色,而它们也

CLIP-seq—动物miRNA靶基因筛选新方法

CLIP-seq,即紫外交联免疫沉淀结合高通量测序(crosslinking-immunprecipitation and high-throughput sequencing),是一项在全基因组水平揭示RNA分子与RNA结合蛋白相互作用的革命性技术。其主要原理是基于RNA分子与RNA结合蛋白在紫外 照射下发生耦联,以RNA结合蛋白的特异性抗体将RNA-蛋白质复合体沉淀之后,回收其中的RNA